Matthew Moyle

Matthew Moyle worked as the Head of Expression Profiling Department at Amgen, Inc. from 1995 to 2001.
He then worked as a Scientist at Genentech, Inc. from 2001 to 2005.
After that, he worked as a Group Leader at Corvas International, Inc. He was the Vice President of Biotherapeutics at Boehringer Ingelheim GmbH from 2010 to 2015.
He also worked as the Vice President of Research at Tanox, Inc. and as the Chief Scientific Officer and Senior Vice President at Theraclone Sciences, Inc. from 2007 to 2010.
In 2016 and 2017, he was the Chief Scientific Officer at AnaptysBio, Inc. He also worked as the Vice President of Biotherapeutics at Boehringer Ingelheim Pharmaceuticals, Inc. Dr. Moyle received his undergraduate and doctorate degrees from the University of Toronto.